Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Blackburn, Beth"'
1
Akademický článek
Weekly touch calls with high-risk cohort of patients with commercial Medicare Advantage to reduce avoidable hospital admissions.
Autor: Blackburn, Beth, Hart, Sharon
Publikováno v: Journal of Clinical Oncology; 2024 Supplement 10, Vol. 20, p282-282, 19p
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Crystal Methamphetamine Associated Heart Failure among Native Hawaiians and Pacific Islanders
Autor: Leonard, Ann E., Blackburn, Beth, Mau, Marjorie K., Vawer, May, Seto, Todd B.
Publikováno v: In Journal of Cardiac Failure 2011 17(8) Supplement:S67-S67
Zobrazit plný text záznamu
7
Akademický článek
Insights in Public Health: Hana Pu No Ke Ola O Hana ("Working Together for the Health of Hana"): Our 14-year CBPR Journey.
Autor: Vawer M; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Rutiz R; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Tukuafu V; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Whatley K; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Hanchett K; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Kahaleuahi L; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Park L; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Minn M; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Blackburn B; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Young M; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Muneno A; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Taira DA; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Sentell T; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS)., Seto TB; The Queen's Medical Center, Honolulu , HI (MV, BB, MY, AM, TBS).; John A. Burns School of Medicine, University of Hawai'i Honolulu, HI (TBS).; Ma Ha Hana Ka 'Ike, Hana Maui, HI (RR, VT, KW, KH, LK, LP, MM).; Office of Public Health Studies, University of Hawai'i, Honolulu, HI (TS).
Publikováno v: Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health [Hawaii J Med Public Health] 2019 Mar; Vol. 78 (3), pp. 111-114.
Zobrazit plný text záznamu
8
Akademický článek
Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial.
Autor: Goodwin PJ; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA. pgoodwin@mtsinai.on.ca., Segal RJ; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Vallis M; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Ligibel JA; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Pond GR; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Robidoux A; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Blackburn GL; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Findlay B; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Gralow JR; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Mukherjee S; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Levine M; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA., Pritchard KI; Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Jul 20; Vol. 32 (21), pp. 2231-9. Date of Electronic Publication: 2014 Jun 16.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje